What is a stock summary page? Click here for an overview.
Business Description
HealthEquity Inc
NAICS : 519190
SIC : 8099
ISIN : US42226A1079
Compare
Compare
Traded in other countries / regions
HQY.USA2HE.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2014-07-31Description
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 3.27 | |||||
| Interest Coverage | 3.35 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.17 | |||||
| Beneish M-Score | -2.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.1 | |||||
| 3-Year EBITDA Growth Rate | 43.7 | |||||
| 3-Year EPS without NRI Growth Rate | 32.9 | |||||
| 3-Year Book Growth Rate | 3.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 19.76 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 9.95 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.33 | |||||
| 9-Day RSI | 35.85 | |||||
| 14-Day RSI | 36.02 | |||||
| 3-1 Month Momentum % | 13.38 | |||||
| 6-1 Month Momentum % | 38.76 | |||||
| 12-1 Month Momentum % | 32.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.06 | |||||
| Quick Ratio | 3.06 | |||||
| Cash Ratio | 1.89 | |||||
| Days Sales Outstanding | 33.12 | |||||
| Days Payable | 11.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.1 | |||||
| Shareholder Yield % | -0.5 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.78 | |||||
| Operating Margin % | 16.91 | |||||
| Net Margin % | 8.06 | |||||
| FCF Margin % | -13.8 | |||||
| ROE % | 4.59 | |||||
| ROA % | 2.87 | |||||
| ROIC % | 5.68 | |||||
| 3-Year ROIIC % | 56.46 | |||||
| ROC (Joel Greenblatt) % | 179.36 | |||||
| ROCE % | 5.45 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 81.41 | |||||
| Forward PE Ratio | 24.39 | |||||
| PE Ratio without NRI | 33.1 | |||||
| Shiller PE Ratio | 170.65 | |||||
| Price-to-Owner-Earnings | 129.22 | |||||
| PEG Ratio | 1.9 | |||||
| PS Ratio | 6.56 | |||||
| PB Ratio | 3.63 | |||||
| Price-to-Operating-Cash-Flow | 23.17 | |||||
| EV-to-EBIT | 47.22 | |||||
| EV-to-Forward-EBIT | 30.19 | |||||
| EV-to-EBITDA | 24.6 | |||||
| EV-to-Revenue | 6.95 | |||||
| EV-to-Forward-Revenue | 6.46 | |||||
| EV-to-FCF | -50.38 | |||||
| Price-to-GF-Value | 0.97 | |||||
| Price-to-Projected-FCF | 3.63 | |||||
| Price-to-DCF (Earnings Based) | 1.06 | |||||
| Price-to-Median-PS-Value | 0.74 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.68 | |||||
| Earnings Yield (Greenblatt) % | 2.12 | |||||
| FCF Yield % | -2.16 | |||||
| Forward Rate of Return (Yacktman) % | 20.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HQY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HealthEquity Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,199.774 | ||
| EPS (TTM) ($) | 1.09 | ||
| Beta | 0.29 | ||
| 3-Year Sharpe Ratio | 0.78 | ||
| 3-Year Sortino Ratio | 1.49 | ||
| Volatility % | 35.4 | ||
| 14-Day RSI | 36.02 | ||
| 14-Day ATR ($) | 4.239662 | ||
| 20-Day SMA ($) | 93.002 | ||
| 12-1 Month Momentum % | 32.58 | ||
| 52-Week Range ($) | 65.01 - 115.59 | ||
| Shares Outstanding (Mil) | 86.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HealthEquity Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HealthEquity Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
HealthEquity Inc Frequently Asked Questions
What is HealthEquity Inc(HQY)'s stock price today?
The current price of HQY is $88.74. The 52 week high of HQY is $115.59 and 52 week low is $65.01.
When is next earnings date of HealthEquity Inc(HQY)?
The next earnings date of HealthEquity Inc(HQY) is 2025-06-03 Est..
Does HealthEquity Inc(HQY) pay dividends? If so, how much?
HealthEquity Inc(HQY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers